« Return to News | Technology Solutions

DecisionView unveils StudyOptimizer 4.4

Wednesday, January 11, 2012 03:42 PM

DecisionView, a leading provider of web software solutions, has released StudyOptimizer 4.4 to help clinical trial organizations plan, forecast and track patient enrollment.

The new version of StudyOptimizer focuses on cost modeling and visibility to enable pharmaceutical companies to easily optimize the time and cost tradeoffs for their clinical trial enrollment plans. In addition, when studies go off track, the new features allow users to model and estimate the cost of different rescue scenarios.

"In planning clinical trials, patient recruitment and enrollment is a major potential source of delays," said Alan Louie, research director at IDC Health Insights. "With as much as 50% of trial project plans requiring rescue and rework, the cost of inefficiency can be high."

DecisionView said StudyOptimizer 4.4 aims to help optimize clinical trials and bring down drug development costs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.